Search Count: 38,727
 |
Crystal Structure Of The Dnak C-Terminus With The Inhibitor Pet-16
Organism: Escherichia coli
Method: X-RAY DIFFRACTION Resolution:3.45 Å Release Date: 2014-09-10 Classification: Chaperone/Chaperone inhibitor Ligands: 3JE |
Organism: Escherichia coli
Method: X-RAY DIFFRACTION
Release Date: 2014-09-10
Ligands: 3JE
 |
Hsp90 Alpha N-Terminal Domain In Complex With A Tricyclic Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2014-01-29 Classification: Chaperone/chaperone Inhibitor Ligands: GOL, WHA, MG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2014-01-29
Ligands: GOL, WHA, MG
 |
Identification Of Novel Hsp90/Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration Of Potential Utility In Treating Cns Disorders Such As Huntington'S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.82 Å Release Date: 2014-12-24 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: 2Q8 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2014-12-24
Ligands: 2Q8
 |
Identification Of Novel Hsp90/Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration Of Potential Utility In Treating Cns Disorders Such As Huntington'S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.93 Å Release Date: 2014-04-09 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: 2QA |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2014-04-09
Ligands: 2QA
 |
Identification Of Novel Hsp90/Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration Of Potential Utility In Treating Cns Disorders Such As Huntington'S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.79 Å Release Date: 2014-04-09 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: 2Q9 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2014-04-09
Ligands: 2Q9
 |
Identification Of Novel Hsp90/Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration Of Potential Utility In Treating Cns Disorders Such As Huntington'S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.86 Å Release Date: 2014-04-09 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: FGH |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2014-04-09
Ligands: FGH
 |
Identification Of Novel Hsp90 / Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration Of Potential Utility In Treating Cns Disorders Such As Huntington S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.96 Å Release Date: 2014-04-09 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: 2R6 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2014-04-09
Ligands: 2R6
 |
Crystal Structure Of The Human Hsp90-Alpha N-Domain Bound To The Hsp90 Inhibitor Fj1
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2013-05-15 Classification: Chaperone/Chaperone Inhibitor Ligands: FJ1 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2013-05-15
Ligands: FJ1
 |
Crystal Structure Of Human Hsp90 With Jr9
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2014-11-05 Classification: Chaperone/Chaperone Inhibitor Ligands: JR9 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2014-11-05
Ligands: JR9
 |
Structure Of Human Activated Thrombin-Activatable Fibrinolysis Inhibitor, Tafia, In Complex With Tick-Derived Funnelin Inhibitor, Tci.
Organism: Rhipicephalus bursa, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2010-02-16 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: ZN, GLY, GOL, CL, CA, K |
Organism: Rhipicephalus bursa, Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2010-02-16
Ligands: ZN, GLY, GOL, CL, CA, K
 |
Optimization Of Potent, Selective, And Orally Bioavailable Pyrrolodinopyrimidine-Containing Inhibitors Of Heat Shock Protein 90. Identification Of Development Candidate 2-Amino-4-{4-Chloro-2-[2-(4-Fluoro-1H-Pyrazol-1-Yl)Ethoxy]-6-Methylphenyl}-N-(2,2-Difluoropropyl)-5,7-Dihydro-6H-Pyrrolo[3,4-D]Pyrimidine-6-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2011-04-27 Classification: Chaperone/Chaperone inhibitor Ligands: WOE |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2011-04-27
Ligands: WOE
 |
Optimization Of Potent, Selective, And Orally Bioavailable Pyrrolodinopyrimidine-Containing Inhibitors Of Heat Shock Protein 90. Identification Of Development Candidate 2-Amino-4-{4-Chloro-2-[2-(4-Fluoro-1H-Pyrazol-1-Yl)Ethoxy]-6-Methylphenyl}-N-(2,2-Difluoropropyl)-5,7-Dihydro-6H-Pyrrolo[3,4-D]Pyrimidine-6-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2011-04-27 Classification: Chaperone/Chaperone inhibitor Ligands: FU5 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2011-04-27
Ligands: FU5
 |
Optimization Of Potent, Selective, And Orally Bioavailable Pyrrolodinopyrimidine-Containing Inhibitors Of Heat Shock Protein 90. Identification Of Development Candidate 2-Amino-4-{4-Chloro-2-[2-(4-Fluoro-1H-Pyrazol-1-Yl)Ethoxy]-6-Methylphenyl}-N-(2,2-Difluoropropyl)-5,7-Dihydro-6H-Pyrrolo[3,4-D]Pyrimidine-6-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2011-04-27 Classification: Chaperone/Chaperone inhibitor Ligands: FU7, PO4 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2011-04-27
Ligands: FU7, PO4
 |
Optimization Of Potent, Selective, And Orally Bioavailable Pyrrolodinopyrimidine-Containing Inhibitors Of Heat Shock Protein 90. Identification Of Development Candidate 2-Amino-4-{4-Chloro-2-[2-(4-Fluoro-1H-Pyrazol-1-Yl)Ethoxy]-6-Methylphenyl}-N-(2,2-Difluoropropyl)-5,7-Dihydro-6H-Pyrrolo[3,4-D]Pyrimidine-6-Carboxamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.65 Å Release Date: 2011-04-27 Classification: Chaperone/Chaperone inhibitor Ligands: FU3 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2011-04-27
Ligands: FU3
 |
Structure Of A Sych-Yoph Chaperone-Effector Complex
Organism: Yersinia pestis, Yersinia enterocolitica
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2013-03-27 Classification: Chaperone/Chaperone Effector |
Organism: Yersinia pestis, Yersinia enterocolitica
Method: X-RAY DIFFRACTION
Release Date: 2013-03-27
 |
Hsp90 Alpha N-Terminal Domain In Complex With An Inhibitor Ro4919127
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2011-09-14 Classification: Chaperone/Chaperone inhibitor Ligands: B2T |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2011-09-14
Ligands: B2T
 |
Hsp90 Alpha N-Terminal Domain In Complex With A Macrocyclic Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.39 Å Release Date: 2012-07-18 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: MES, VHA |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2012-07-18
Ligands: MES, VHA
 |
Hsp90 Alpha N-Terminal Domain In Complex With An Inhibitor Ch4675194
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2011-09-14 Classification: Chaperone/Chaperone inhibitor Ligands: B2K |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2011-09-14
Ligands: B2K
 |
Hsp90 Alpha N-Terminal Domain In Complex With An Inhibitor Ro1127850
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2011-09-14 Classification: Chaperone/Chaperone inhibitor Ligands: B2L |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2011-09-14
Ligands: B2L
 |
Hsp90 Alpha N-Terminal Domain In Complex With An Inhibitor Ch5015765
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.35 Å Release Date: 2011-09-14 Classification: Chaperone/Chaperone inhibitor Ligands: GOL, B2X, MG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2011-09-14
Ligands: GOL, B2X, MG